Upon mild liver injury, new hepatocytes originate from preexisting hepatocytes. However, if hepatocyte proliferation is impaired, a manifestation of severe liver injury, biliary epithelial cells (BECs) contribute to new hepatocytes through BEC dedifferentiation into liver progenitor cells (LPCs), also termed oval cells or hepatoblast-like cells (HB-LCs), and subsequent differentiation into hepatocytes. Despite the identification of several factors regulating BEC dedifferentiation and activation, little is known about factors involved in the regulation of LPC differentiation into hepatocytes during liver regeneration. Using a zebrafish model of near-complete hepatocyte ablation, we show that bone morphogenetic protein (Bmp) signaling is required for BEC conversion to hepatocytes, particularly for LPC differentiation into hepatocytes. We found that severe liver injury led to the up-regulation of genes involved in Bmp signaling, including smad5, tbx2b, and id2a, in the liver. Bmp suppression did not block BEC dedifferentiation into HB-LCs; however, the differentiation of HB-LCs into hepatocytes was impaired due to the maintenance of HB-LCs in an undifferentiated state. Later Bmp suppression did not affect HB-LC differentiation but increased BEC number through proliferation. Notably, smad5, tbx2b, and id2a mutants exhibited similar liver regeneration defects as those observed in Bmp-suppressed livers. Moreover, BMP2 addition promoted the differentiation of a murine LPC line into hepatocytes in vitro. Conclusions: Bmp signaling regulates BEC-driven liver regeneration through smad5, tbx2b, and id2a: it regulates HB-LC differentiation into hepatocytes through tbx2b and BEC proliferation through id2a; our findings provide insights into promoting innate liver regeneration as a novel therapy. (HEPATOLOGY 2017;66:1616-1630.
(LPCs), also called oval cells or hepatoblast-like cells (HB-LCs), and subsequently give rise to hepatocytes. (2) Previously, controversies existed regarding the relative contribution of BEC-driven liver regeneration (3) ; however, recent studies in zebrafish (4, 5) and mice (6) have resolved this controversy by showing the extensive contribution of BECs to hepatocytes upon severe liver injury. In mice, hepatocyte-specific Mdm2 deletion completely blocks hepatocyte proliferation, additionally induces hepatocyte senescence and apoptosis, and subsequently elicits oval cell activation. These oval cells later give rise to hepatocytes, leading to a full liver recovery. (6) In zebrafish studies, the near-complete ablation of hepatocytes elicits the extensive contribution of BECs to hepatocytes through the dedifferentiation of BECs into HB-LCs and subsequent differentiation of the HBLCs into hepatocytes. (4, 5) Oval cells are frequently observed in diseased livers, and their number positively correlates with disease severity. (7) Because patients suffering from severe liver diseases have limited treatment options and present with an abundance of hepatic oval cells, promoting the differentiation of oval cells into hepatocytes is deemed an effective therapeutic strategy. Developing such therapies requires a deeper understanding of the mechanisms by which oval cells differentiate into hepatocytes in vivo. Although several factors, such as fibroblast growth factor 7 (FGF7) (8) and TWEAK, (9) which can induce oval cell activation in vivo, have been identified, factors that regulate oval cell differentiation into hepatocytes in vivo are unknown, mainly due to the lack of an animal model for BEC-driven liver regeneration. However, recent reports of zebrafish and mouse liver injury models, in which BECs extensively contribute to regenerated hepatocytes, present an opportunity to investigate the mechanisms underlying oval cell differentiation into hepatocytes.
Using the zebrafish BEC-driven liver regeneration model combined with targeted chemical screening, we recently reported on the role of bromodomain extraterminal proteins in BEC dedifferentiation into HB-LCs and the proliferation of newly generated hepatocytes. (10) Using the same zebrafish model, we now show the essential role of bone morphogenetic protein (Bmp) signaling in HB-LC differentiation into hepatocytes. Bmp signaling plays important roles in early liver development, such as hepatoblast specification and proliferation. (11, 12) Despite its clear role in early liver development, the role of Bmp signaling in liver regeneration has not been clearly defined. Current literature provides confounding results that BMP2 (13) and BMP4 (14) negatively, while BMP7 (15) positively, regulate hepatocyte-driven liver regeneration after partial hepatectomy in rodents. Moreover, there is no report on the role of Bmp signaling in BEC-driven liver regeneration. Given the important role of Bmp signaling in early liver development and its positive effect on regeneration of other organs, including the heart, (16) we hypothesized that Bmp signaling might regulate BEC-driven liver regeneration. Our finding that the hepatic expression of several genes implicated in Bmp signaling, including smad5, was up-regulated during BEC-driven liver regeneration further supported our hypothesis. In this study, we report that Bmp signaling regulates two distinct steps of BECdriven liver regeneration: (1) HB-LC differentiation into hepatocytes and (2) the proliferation of newly generated BECs. Table S1 .
Materials and Methods

ZEBRAFISH LINES
HEPATOCYTE ABLATION AND DORSOMORPHIN HOMOLOG 1 TREATMENT
Hepatocyte ablation was performed by treating Tg(fabp10a:CFP-NTR) larvae with 10 mM metronidazole (Mtz) in egg water supplemented with 0.2% dimethyl sulfoxide and 0.2 mM 1-phenyl-2-thiourea, as described. (17) To suppress Bmp signaling, 10 lM dorsomorphin homolog 1 (DMH1; Tocris, Bristol, UK) was used.
RNA SEQUENCING ANALYSIS
Over 100 livers were manually dissected for each condition (three nonablating controls at 4.25, 5.25, and 6 days postfertilization (dpf) and four regenerating livers at A18h, R6h, R12h, and R24h); total RNA was extracted from the dissected livers using the RNeasy Mini Kit (Qiagen, Valencia, CA). This RNA preparation was repeated three times, and three replicate RNA samples were mixed. These mixed samples were processed for single-end deep-transcriptome sequencing using the Illumina HiSeq 2000 platform, of which service was provided from Tufts University Core Facility. Galaxy was used to analyze the sequencing reads.
Additional methods are available in Supporting Information.
Results
Bmp SIGNALING IS REQUIRED FOR BEC-DRIVEN LIVER REGENERATION
We have established a zebrafish liver injury model in which BECs extensively contribute to hepatocytes. (4) Specifically, Tg(fabp10a:CFP-NTR) fish express cyan fluorescent protein (CFP)-nitroreductase (NTR) under the hepatocyte-specific fabp10a promoter; treatment with Mtz, which is converted into a cytotoxic drug by NTR, results in hepatocyte-specific ablation in the transgenic fish. In this model, severe hepatocyte ablation induces the dedifferentiation of BECs into HB-LCs, which then differentiate into hepatocytes, thereby leading to a full liver recovery. To understand the molecular mechanisms underlying BEC-driven liver regeneration, we performed RNA sequencing analyses and compared gene expression profiles between control and regenerating livers at multiple time points during the regeneration. Through this analysis and subsequent validation with RT-PCR and whole-mount in situ hybridization (WISH) (Supporting Fig. S1 ), we found that genes implicated in the Bmp signaling pathway, such as smad5, id2a, and tbx2b, were upregulated in regenerating livers at regeneration (R) 6h compared with controls ( Fig. 1A-1C ). Bmp signaling plays an essential role in hepatoblast specification and liver growth during liver development, (11, 12) but its role in liver regeneration has not been clearly defined. Thus, to determine whether Bmp signaling was required for BECdriven liver regeneration, we applied the selective Bmp inhibitor DMH1, which has been widely used in zebrafish. During BEC-driven liver regeneration, a hepatoblast/hepatocyte marker, hepatocyte nuclear factor 4a (Hnf4a), is induced in BECs; and the expression of Prox1, a marker for hepatoblasts, hepatocytes, and BECs, is also up-regulated in BECs. (4) In addition, the expression of Alcam, a good marker of zebrafish BECs, (18) is sustained in HB-LCs but disappears from HB-LCs when these cells differentiate into hepatocytes.
(4) DMH1 treatment from ablation (A) 0h greatly repressed Hnf4a, but not Prox1 or Alcam, expression at R0h (Fig. 1D) . Intriguingly, DMH1 treatment after hepatocyte ablation (from R0h) significantly increased the number of BECs at R30h, as assessed by Alcam and Tp1:H2B-mCherry expression (Fig. 1E) . The Tg(Tp1:H2B-mCherry) line, which expresses stable H2B-mCherry fusion proteins under the Tp1 promoter containing the Notch-responsive element, reveals BECs in the liver. (19) Collectively, these data indicate the essential roles of Bmp signaling in BEC-driven liver regeneration.
INHIBITION OF Bmp SIGNALING BLOCKS HB-LC DIFFERENTIATION INTO HEPATOCYTES
Next, we investigated in detail the effect of Bmp inhibition on earlier stages of BEC-driven liver regeneration. We first determined if Bmp inhibition blocked the dedifferentiation of BECs into HB-LCs. By examining Hnf4a expression at various time points between A24h and A36h, we found that Hnf4a induction in BECs occurred around A33h and that its expression became stronger at A36h (Supporting Fig.  S2A , arrows). As Hnf4a induction in BECs is indicative of BEC dedifferentiation, (4) these data suggest that BECs dedifferentiate into HB-LCs around A33h. This observation was further supported by the expression of fabp10a:rasGFP (Supporting Fig. S2B ), which is not expressed in hepatoblasts during liver development but induced in BECs during BEC-driven liver regeneration. (10) At A33h, there were fabp10a:ras GFP 1 cells negative for Hnf4a (Supporting Fig. S2C , arrows) but not vice versa, indicating that fabp10a induction in BECs precedes Hnf4a induction. Although Hnf4a expression in BEC-derived cells was greatly reduced at A36h in DMH1-treated regenerating livers compared with their controls (Fig. 1D) , the initial induction of Hnf4a and fabp10a:rasGFP in BECs at A33h appeared unaffected in DMH1-treated regenerating livers (Supporting Fig. S2A ,B). These data together with normal Prox1 expression in HBLCs indicate that Bmp inhibition does not block the dedifferentiation of BECs.
Given that Hnf4a is the master regulator of hepatocyte differentiation, (20) the reduced Hnf4a expression upon Bmp inhibition (Fig. 1D ) suggests a role for Bmp signaling in HB-LC differentiation into hepatocytes. To address this possibility, we sought to examine DMH1-treated regenerating larvae at later stages, such as R24h. However, continuous DMH1 treatment from A0h killed most regenerating larvae before R24h, preventing examination of the regenerating livers at later stages. By treating ablating larvae with DMH1 from different time points, we found that DMH1 treatment from A33h also reduced Hnf4a expression at R6h ( Fig. 2A ) but did not kill regenerating larvae as late as R24h. At R24h, A33h DMH1-treated regenerating livers exhibited the following phenotypes: (1) sustained Alcam expression in most BEC-derived Tp1:H2B-mCherry 1 cells (Fig. 2B) ; (2) sustained Notch activity, as revealed by Tp1:VenusPEST expression, (21) throughout regenerating livers (Fig. 2C) ; and (3) no expression of hepatocyte markers Bhmt, cp, and gc ( Fig. 2D,E) , indicating a defect in HB-LC differentiation into hepatocytes. Despite a lack of hepatocyte marker expression, the expression of foxa3 and prox1a, which are expressed in hepatoblasts, was unaffected in DMH1-treated regenerating livers (Fig. 2E ). Expression of fabp10a, which is expressed in HB-LCs (Supporting Fig. S2B ), was also unaffected (Fig. 2D,E) . In addition to the pharmacologic inhibition, we blocked Bmp signaling using the Tg(hs:dnBmpr1) line that expresses dominant-negative Bmpr1 under the hsp70l heat-shock promoter. Overexpression of dnBmpr1 through a single heat shock at A30h resulted in sustained Notch activity and reduced Hnf4a expression in regenerating livers at R12h (Fig. 2F ). All of these data indicate a role of Bmp signaling in HB-LC differentiation into hepatocytes.
INHIBITION OF Bmp SIGNALING MAINTAINS HB-LCs IN THEIR UNDIFFERENTIATED STATE
Based on sustained Notch activity and Alcam expression in A33h DMH1-treated regenerating livers, we hypothesized that HB-LCs that failed to differentiate into hepatocytes remained as undifferentiated HB-LCs in DMH1-treated regenerating livers. To test this hypothesis, we used Cre/loxP-mediated lineage tracing and determined the lineages of HB-LCs. To label HBLCs, we used two Cre lines, Tg(Tp1:CreERT2) that expresses CreERT2 under the Tp1 promoter (22) and Tg(fabp10a:CreERT2) that expresses CreERT2 under the fabp10a promoter. (4) Because Notch activity is strong in BECs but weak in HB-LCs, the former line labels most BECs but a few HB-LCs. Likewise, because fabp10a expression is strong in hepatocytes but weak in HB-LCs, the latter line labels most hepatocytes but a few HB-LCs. When Tp1:CreERT2 and fabp10a:-CreERT2 were activated by 4-hydroxytamoxifen treatment from A33h to R6h, 95% of BECs and 96% of hepatocytes, respectively, were labeled at R54h (Fig. 3B) . However, few hepatocytes were labeled by Tp1:CreERT2 activation (Fig. 3C) , and few BECs were labeled by fabp10a:CreERT2 activation (Fig. 3D) , indicating that few HB-LCs were labeled in these Cre activation settings. This low efficiency of HB-LC labeling can be explained by the weak Notch activity and weak fabp10a expression in HB-LCs and the short duration of HB-LCs in the zebrafish liver injury model. If HB-LCs fail to differentiate and remain in a progenitor-like state, more HB-LCs will be labeled in the Cre activation settings; thus, more hepatocytes and BECs were labeled by Tp1:CreERT2 and fabp10a:CreERT2, respectively. We observed these phenomena in regenerating livers treated with DMH1 from A33h to R6h (Fig. 3C,D) , strongly suggesting that Bmp inhibition maintains HB-LCs in their undifferentiated state.
INHIBITION OF Bmp SIGNALING AFTER HEPATOCYTE ABLATION INCREASES BEC NUMBER IN REGENERATING LIVERS THROUGH PROLIFERATION
Unlike its treatment from A33h, DMH1 treatment from R0h did not affect HB-LC differentiation into hepatocytes, as assessed by cp and gc expression (Supporting Fig. S3 ). Given the increased number of BECs upon DMH1 treatment from R0h (Fig. 1E) , we determined the latest time point from which DMH1 treatment still increased BEC number. We found that DMH1 treatment from R12h, but not R24h, significantly increased BEC number (Fig. 4A) . Using a cellcycle reporter line, Tg(Tp1:mAGFP-gmnn), which reveals BECs in the S/G 2 /M (but not G 0 /G 1 ) phases of the cell cycle, we observed that BEC proliferation was significantly increased in DMH1-treated regenerating livers at R30h compared with their controls (Fig.  4B) . In addition to the chemical inhibition of Bmp signaling, overexpression of dnBmpr1 through a single heat shock at R8h increased BEC proliferation in regenerating livers at R30h (Fig. 4C,D) . Altogether, these data indicate that Bmp signaling controls the number of BECs in regenerating livers by temporarily suppressing their proliferation.
smad5 MUTANTS EXHIBIT A DEFECT IN HB-LC DIFFERENTIATION INTO HEPATOCYTES
Given the up-regulation of genes implicated in Bmp signaling, such as smad5, tbx2b, and id2a, in regenerating livers (Fig. 1A-C) , we determined if DMH1 treatment suppressed this up-regulation. Indeed, quantitative RT-PCR and WISH showed a reduction of the hepatic expression of smad5, tbx2b, and id2a in DMH1-treated regenerating livers at R6h compared with their controls (Fig. 5A) , suggesting a potential role for these genes in mediating Bmp signaling during BEC-driven liver regeneration. To test this possibility, we examined BEC-driven liver regeneration in smad5 mutants. Smad5, together with Smad1 and Smad9, known as receptor-regulated Smads (R-Smads), relays Bmp signaling from the cell surface to the nucleus. (23) Zebrafish smad5 -/-mutants started to die from 3 dpf, but smad5 mRNA injection into one cell-stage embryos increased their survival time, (24) allowing for our liver regeneration assay. Although the mRNA-injected mutants had a smaller liver than their siblings, liver development occurred, as observed by liver growth (Supporting Fig. S4B ) and the branching of the intrahepatic biliary structure (Supporting Fig. S4C ). Because liver size was smaller in the mRNA-injected mutants than in wild type, we applied Mtz from 5 dpf, when the mutant liver size was similar to that of 3.5-dpf wild-type liver. In this rescue setting, the smad5 -/-mutants exhibited sustained Notch activity and Alcam expression throughout regenerating livers (Fig. 5B-D) and no cp, but faint gc, expression (Fig. 5E) at R24h, recapitulating the HB-LC differentiation defects observed in A33h DMH1-treated regenerating livers. Expression of tbx2b and id2a in regenerating livers also appeared to be reduced in the smad5 -/-mutants compared with their siblings (Fig. 5E ), further supporting that Bmp signaling regulates tbx2b and id2a expression in regenerating livers. When examined at R48h, continuous DMH1 treatment from A33h was fatal for the zebrafish larvae recovering from severe liver injury, preventing the analysis of BECdriven liver regeneration at later stages. However, the smad5 -/-mutants recovered at R48h from the initial regeneration defects, as displayed by the rapid growth of their regenerating livers (Supporting Fig. S4E ), normal Notch activity (Supporting Fig. S4F ), and recovered cp and gc expression (Supporting Fig. S4G ). Altogether, data from smad5 mutant analyses indicate the role of smad5 in BEC-driven liver regeneration.
tbx2b MUTANTS EXHIBIT A DEFECT IN HB-LC DIFFERENTIATION INTO HEPATOCYTES
TBX3, a T-box transcription factor, promotes hepatoblast proliferation and maintains the expression of HNF4A and CEBPA, two key transcription factors regulating hepatocyte differentiation, in hepatoblasts. (25) TBX2, a close homolog of TBX3, is required for the development of the heart, pharyngeal arch, and optic cup; importantly, its expression in these tissues is regulated by Bmp signaling. (26) Thus, to determine if tbx2b was required for BEC-driven liver regeneration, we used zebrafish tbx2b mutants because they develop with normal body morphology (Supporting Fig. S5A ) and survive long enough for our liver regeneration assay. (27) Despite the absence of liver developmental defects (Supporting Fig. S5B) (Fig. 6A-C) but also showed sustained Alcam expression at R24h (Fig.  6D) . This phenotype was severe in 40% of the mutants, having few Bhmt 1 hepatocytes, but mild in the rest of them, having a significant number of the hepatocytes (Fig. 6B-D) . To determine whether the observed phenotype at R24h later recovered, we examined regenerating livers at R48h. All mutants at R48h still contained a significant number of Tp1: VenusPEST -/Tp1:H2B-mCherry 1 cells negative for Hnf4a (Supporting Fig. S5C ), suggesting that, in the absence of Tbx2b, BEC-derived cells that failed to differentiate into hepatocytes at R24h do not recover at a later time point. We next examined if BEC dedifferentiation was affected in tbx2b -/-mutants. Although Hnf4a expression in regenerating livers at R6h was reduced in the mutants compared with their siblings, fabp10a:rasGFP expression appeared unaffected in the mutants (Supporting Fig. S5D ), suggesting that BECs dedifferentiate into HB-LCs in the absence of Tbx2b. Altogether, data from tbx2b mutant analyses indicate the crucial role of tbx2b in BEC-driven liver regeneration, in particular HB-LC differentiation into hepatocytes.
id2a MUTANTS TEMPORARILY DISPLAY AN EXCESS OF BECs IN REGENERATING LIVERS
Id2 is a well-known downstream target gene of Bmp signaling in many tissues, including pancreatic epithelia (28) ; the mouse Id2 promoter contains BMPresponsive elements. (29) id2a, the zebrafish ortholog of mouse Id2, is also regulated by Bmp signaling in cranial neural crest cells. (30) Not only are Id2 and id2a the direct targets of Bmp signaling but they also mediate the effect of Bmp signaling in these tissues. Given its BEC-specific expression in the developing liver (31) and its regulation by Bmp signaling in regenerating livers (Fig. 5A) , we hypothesized that id2a served as a mediator of Bmp signaling in BEC-driven liver regeneration. Using transcription activator-like effector nuclease genome editing technology, we generated id2a mutants containing a 22-bp deletion in the first exon. The mutant larvae did not exhibit any liver developmental defects (Supporting Fig. S6A,B) and grew normally to adults. BEC-driven liver regeneration appeared unaffected in id2a -/-mutants, as assessed by Hnf4a expression at R6h (Fig. 7B) and gc expression at R24h (Fig. 7C) ; however, the mutant regenerating livers had significantly more BECs than controls at R30h (Fig.  7D) , resembling the excessive BEC phenotype seen in regenerating livers treated with DMH1 from R0h. This increased BEC number was due to increased proliferation, as revealed by 5-ethynyl-2 0 -deoxyuridine labeling (Fig. 7E) . However, this BEC phenotype was temporary because there was no difference in BEC number between wild-type and id2a -/-mutant regenerating livers at R72h (Supporting Fig. S6C ). Altogether, data from id2a mutant analyses suggest that id2a mediates, in part, the effect of Bmp signaling on BEC proliferation during BEC-driven liver regeneration. 
BMP2 ADDITION PROMOTES THE DIFFERENTIATION OF A MURINE LPC LINE INTO HEPATOCYTES IN VITRO
To explore whether the findings from the zebrafish liver injury model can be translated to mammals, we used a murine LPC line that was established from 3,5-diethoxycarbonyl-1,4-dihydrocollidine dietfed mice. (32) These cells can efficiently differentiate into hepatocytes or BECs depending on culture conditions. (32) In the hepatocyte differentiation condition, addition of BMP2 significantly increased the expression of three hepatocyte markers, G6pc, Tat, and Tdo2 (Fig.  8) , consistent with the findings in zebrafish.
Discussion
Using the zebrafish hepatocyte ablation model, we elucidate two distinct roles of Bmp signaling in BECdriven liver regeneration: (1) initially, Bmp signaling regulates HB-LC differentiation into hepatocytes; (2) later, Bmp signaling controls the proliferation of newly generated BECs. By analyzing the mutants of smad5, tbx2b, and id2a genes involved in the Bmp signaling pathway, we discovered that Smad5 is the main receptor-regulated Smad during BEC-driven liver regeneration and that Tbx2b and Id2a mediate its effect on HB-LC differentiation into hepatocytes and on BEC proliferation, respectively.
Bmp, (11, 12) Fgf, (12, 33) and Wnt/b-catenin (34) signaling are implicated in hepatoblast specification and proliferation during liver development. Given that regeneration often recapitulates development and key developmental factors are reused during regeneration, these signaling pathways may also regulate liver regeneration. During hepatocyte-driven liver regeneration, both Wnt/b-catenin (35) and Fgf (36) signaling promote hepatocyte proliferation. During BEC-driven liver regeneration, Wnt/b-catenin signaling promotes oval cell proliferation (37) and Fgf signaling induces oval cell activation. (8) In contrast to Wnt/b-catenin and Fgf signaling, the influence of Bmp signaling on hepatocyte proliferation during hepatocyte-driven liver regeneration is ligand-dependent: BMP4 signaling through Alk3 represses hepatocyte proliferation, whereas BMP7 signaling through Alk2 promotes hepatocyte proliferation. (14) Previous in vitro studies have reported on the role of BMP signaling in the differentiation of LPCs into hepatocytes: BMP4 treatment induced the differentiation of rat hepatic progenitor cells (38) and CD133 1 hepatic cancer stem cells (39) into hepatocytes. Our in vitro and in vivo data support these findings and further reveal the crucial role of Bmp signaling in BEC-driven liver regeneration, specifically during the differentiation phase of LPCs into hepatocytes.
To further elucidate the mechanisms by which Bmp signaling controls BEC-driven liver regeneration, we analyzed tbx2b and id2a mutants. Our RNA sequencing data revealed that at R6h both tbx2b (among the T-box transcription factor genes) and id2a (among the Id family genes) were highly up-regulated in regenerating livers compared with the other tbx and id genes (Supporting Fig. S7A,B) , suggesting their importance in BECdriven liver regeneration. As expected, both tbx2b and id2a expression decreased in both DMH1-treated and smad5 -/-regenerating livers. Importantly, tbx2b -/-mutants exhibited a defect in HB-LC differentiation into hepatocytes and id2a mutants exhibited excessive BECs in regenerating livers at R30h, revealing tbx2b and id2a as the key downstream mediators of Bmp signaling that regulates BEC-driven liver regeneration. Using a morpholino-mediated knockdown approach, we previously reported that during liver development Id2a positively regulates hepatic outgrowth through hepatoblast proliferation and survival. (31) However, we found that during BEC-driven liver regeneration Id2a negatively regulates the proliferation of newly generated BECs. Although we did not detect any developmental defects in the id2a -/-mutants, inconsistent with the morpholino results, this discrepancy might be explained by the genetic compensations that can occur in mutants but not in morphants. (40) Previous rodent studies have highlighted the role of Id1 and Id2 in hepatocyte-driven liver regeneration. Following partial hepatectomy, not only was Id1 upregulated in liver sinusoidal endothelial cells but Id1 -/-mice displayed abnormal liver function and impaired liver regeneration. (41) In fact, following acute liver injury, Id1 was induced downstream of liver sinusoidal endothelial cell-specific up-regulation of chemokine (C-X-C motif) receptors 4 and 7.
(42) As a result, ID1 promotes the secretion of proregenerative angiocrine factors, such as Wnt2 and hepatocyte growth factor, to aid in hepatocyte proliferation after liver injury. (41, 42) Similar to Id1, Id2 levels also increased after partial hepatectomy and bile duct ligation in rats, (43) but its role in liver regeneration has not yet been reported.
While Wnt/b-catenin signaling promotes LPC differentiation into hepatocytes, Notch signaling represses the process. (44, 45) Here, we present Bmp signaling as another regulator of this differentiation process. Because we did not observe any changes in Wnt activity between dimethyl sulfoxide-treated and DMH1-treated regenerating livers (Supporting Fig. S8 ), it appears that Bmp signaling does not affect Wnt/b-catenin signaling. However, sustained, weak Notch activity observed in DMH1-treated regenerating livers suggests that Bmp signaling may suppress Notch signaling. Although it was reported that repression of Notch signaling promotes LPC differentiation into hepatocytes, (44, 45) the hepatocyte differentiation defects observed in DMH1-treated livers were not rescued by inhibiting Notch signaling globally (data not shown). Thus, it is unlikely that Bmp signaling controls LPC differentiation through Wnt/b-catenin or Notch signaling. However, we do not exclude the possibility that Wnt/b-catenin and Notch signaling control LPC differentiation through Bmp signaling.
The zebrafish hepatocyte ablation model has contributed significantly to a better understanding of BEC-driven or LPC-driven liver regeneration. We previously reported that Wnt/b-catenin signaling through Wnt2bb regulates the proliferation of newly generated hepatocytes (4) and that bromodomain extraterminal proteins regulate BEC dedifferentiation and the proliferation and maturation of newly generated hepatocytes. (10) Using the same model, others have also reported on the involvement of Notch signaling in BEC-driven liver regeneration. (46) Here, we provide the gene expression profiles of regenerating livers at four distinct stages, A18h, R6h, R12h, and R24h. Although we focus on Bmp signaling and its downstream target genes in this study, these expression profiles will be useful for identifying other crucial genes involved in regulating BEC-driven liver regeneration.
In summary, we discovered that Bmp signaling regulates HB-LC differentiation into hepatocytes, partly through Tbx2b, and controls the proliferation of newly generated BECs through Id2a. Liver biopsies of human patients suffering from chronic liver diseases display an abundance of oval cells, also known as HBLCs. To promote the differentiation of these oval cells into hepatocytes in these patients, one possible therapy may involve enhancing hepatic Bmp signaling.
